PHENTERMINE RESIN COMPLEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phentermine Resin Complex, and when can generic versions of Phentermine Resin Complex launch?
Phentermine Resin Complex is a drug marketed by Lannett Co Inc and is included in one NDA.
The generic ingredient in PHENTERMINE RESIN COMPLEX is phentermine resin complex. There are seventeen drug master file entries for this compound. Additional details are available on the phentermine resin complex profile page.
Summary for PHENTERMINE RESIN COMPLEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 47 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PHENTERMINE RESIN COMPLEX at DailyMed |
Recent Clinical Trials for PHENTERMINE RESIN COMPLEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kaiser Permanente | Phase 4 |
Wake Forest University Health Sciences | Phase 4 |
Biomedical Research Institute of New Mexico | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for PHENTERMINE RESIN COMPLEX
US Patents and Regulatory Information for PHENTERMINE RESIN COMPLEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lannett Co Inc | PHENTERMINE RESIN COMPLEX | phentermine resin complex | CAPSULE, EXTENDED RELEASE;ORAL | 040872-001 | Jul 28, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lannett Co Inc | PHENTERMINE RESIN COMPLEX | phentermine resin complex | CAPSULE, EXTENDED RELEASE;ORAL | 040872-002 | Jul 28, 2011 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |